Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|August 4, 2022
Cell Trajectory-Related Genes of Lung Adenocarcinoma Predict Tumor Immune Microenvironment and Prognosis of PatientsYu Luo, Xiaheng Deng, Jun Que, et al.
Cell Death & Disease|April 23, 2026
Targeting PTDSS1 to modulate GSH synthesis triggers mitophagy and induces ferroptosis in esophageal squamous cell carcinoma cellsXiao Zhang, Shurui Cao, Chenchen Zhou, et al.
Translational Cancer Research|February 4, 2022
Postoperative diffused alveolar hemorrhage complicated by pneumonia after lung cancer surgery in a patient with liver cirrhosis: a case report and review of literaturesXiaheng Deng, Quan Zhu, Jun Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 1, 2014
A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axisXiao Yang, Yidong Cheng, Pengchao Li, et al.
Scientific Reports|September 11, 2015
GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapyXiaheng Deng, Xiao Yang, Yidong Cheng, et al.
Oncotargets and Therapy|August 29, 2015
Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysisYidong Cheng, Xiaheng Deng, Xiao Yang, et al.
Combinatorial Chemistry & High Throughput Screening|April 20, 2026
Corrigendum to: Effects of SVEP1 on Lung Squamous Cell Carcinoma and its Association with Tumor Mutation Burden, Prognosis, and Immune RegulationYu Luo, Min Zhang, Zhibo Wang, et al.
Combinatorial Chemistry & High Throughput Screening|March 21, 2022
Effects of SVEP1 on Lung Squamous Cell Carcinoma and its Association with Tumor Mutation Burden, Prognosis, and Immune RegulationYu Luo, Min Zhang, Zhibo Wang, et al.
International Journal of Clinical and Experimental Medicine|September 18, 2015
Metabolomics in bladder cancer: a systematic reviewYidong Cheng, Xiao Yang, Xiaheng Deng, et al.
International Journal of Clinical and Experimental Medicine|September 18, 2015
Pharmacogenetic association between XRCC1 polymorphisms and improved outcomes in bladder cancer patients following intravesical instillation of epirubicinPengchao Li, Xiaolei Zhang, Xiaheng Deng, et al.
Pageof 4